Hemenway Trust Co LLC’s Abbott Laboratories Position
Does Hemenway Trust Co LLC own Abbott Laboratories (ABT)? Yes — 337.7K shares worth $35M (+2.79% of its 13F portfolio) as of Q1 2026, up from 336.8K shares the prior filed quarter.
Position Value
$35M
Q1 2026
Shares
337.7K
% of Portfolio
+2.79%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 337.7K | $35M | +2.79% |
| Q4 2025 | 336.8K | $42M | +3.23% |
| Q3 2025 | 342.0K | $46M | +3.51% |
| Q2 2025 | 353.1K | $48M | +3.72% |
| Q1 2025 | 372.2K | $49M | +4.02% |
| Q4 2024 | 357.4K | $40M | +3.28% |
| Q3 2024 | 349.6K | $40M | +3.15% |
| Q2 2024 | 345.3K | $36M | +3.07% |
| Q1 2024 | 343.0K | $39M | +3.38% |
| Q4 2023 | 334.5K | $37M | +3.52% |
| Q3 2023 | 316.9K | $31M | +3.22% |
| Q2 2023 | 310.6K | $34M | +3.32% |
| Q1 2023 | 303.1K | $31M | +3.25% |
| Q4 2022 | 304.8K | $33M | +3.72% |
| Q3 2022 | 294.4K | $28M | +3.35% |
| Q2 2022 | 291.9K | $32M | +3.61% |
| Q1 2022 | 297.1K | $35M | +3.38% |
| Q4 2021 | 288.2K | $41M | +3.69% |
| Q3 2021 | 284.9K | $34M | +3.40% |
| Q2 2021 | 281.3K | $33M | +3.29% |
| Q1 2021 | 273.8K | $33M | +3.59% |
| Q4 2020 | 269.7K | $30M | +3.38% |
| Q3 2020 | 268.7K | $29M | +3.80% |
| Q2 2020 | 268.3K | $25M | +3.41% |
| Q1 2020 | 268.2K | $21M | +3.58% |
| Q4 2019 | 267.3K | $23M | +3.34% |
| Q3 2019 | 267.0K | $22M | +3.50% |
| Q2 2019 | 285.4K | $24M | +3.71% |
| Q1 2019 | 290.6K | $23M | +3.74% |
| Q4 2018 | 270.3K | $20M | +3.99% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hemenway Trust Co LLC’s full portfolio or all institutional holders of ABT.